A simple p53 functional assay for screening cell lines, blood, and tumors
- PMID: 7732013
- PMCID: PMC42082
- DOI: 10.1073/pnas.92.9.3963
A simple p53 functional assay for screening cell lines, blood, and tumors
Abstract
Mutations in the p53 gene are implicated in the pathogenesis of half of all human tumors. We have developed a simple functional assay for p53 mutation in which human p53 expressed in Saccharomyces cerevisiae activates transcription of the ADE2 gene. Consequently, yeast colonies containing wild-type p53 are white and colonies containing mutant p53 are red. Since this assay tests the critical biological function of p53, it can distinguish inactivating mutations from functionally silent mutations. By combining this approach with gap repair techniques in which unpurified p53 reverse transcription-PCR products are cloned by homologous recombination in vivo it is possible to screen large numbers of samples and multiple clones per sample for biologically important mutations. This means that mutations can be detected in tumor specimens contaminated with large amounts of normal tissue. In addition, the assay detects temperature-sensitive mutants, which give pink colonies. We show here that this form of p53 functional assay can be used rapidly to detect germline mutations in blood samples, somatic mutations in tumors, and mutations in cell lines.
Similar articles
-
Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses.Mol Carcinog. 1997 Mar;18(3):171-6. Mol Carcinog. 1997. PMID: 9115587
-
Selective detection of inactivating mutations of the tumor suppressor gene p53 in bladder tumors.J Urol. 1999 Jun;161(6):1973-5. J Urol. 1999. PMID: 10332483
-
Analysis of p53 status in human cell lines using a functional assay in yeast: detection of new non-sense p53 mutation in codon 124.Oncol Rep. 2005 Oct;14(4):901-7. Oncol Rep. 2005. PMID: 16142349
-
FASAY: a simple functional assay in yeast for identification of p53 mutation in tumors.Neoplasma. 1999;46(2):80-8. Neoplasma. 1999. PMID: 10466430 Review.
-
[Functional screening of p53 status in tumor cells using Saccharomyces cerevisiae].Gan To Kagaku Ryoho. 1997 Feb;24(4):466-70. Gan To Kagaku Ryoho. 1997. PMID: 9063485 Review. Japanese.
Cited by
-
An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells.Breast Cancer Res. 2007;9(3):R38. doi: 10.1186/bcr1734. Breast Cancer Res. 2007. PMID: 17573968 Free PMC article.
-
Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome.J Med Genet. 2006 Jun;43(6):531-3. doi: 10.1136/jmg.2005.037952. Epub 2005 Oct 28. J Med Genet. 2006. PMID: 16258005 Free PMC article.
-
Clonal Evolution of TP53 c.375+1G>A Mutation in Pre- and Post- Neo-Adjuvant Chemotherapy (NACT) Tumor Samples in High-Grade Serous Ovarian Cancer (HGSOC).Cells. 2019 Oct 1;8(10):1186. doi: 10.3390/cells8101186. Cells. 2019. PMID: 31581548 Free PMC article.
-
p53-dependent G2 arrest associated with a decrease in cyclins A2 and B1 levels in a human carcinoma cell line.Br J Cancer. 2000 Feb;82(3):642-50. doi: 10.1054/bjoc.1999.0976. Br J Cancer. 2000. PMID: 10682678 Free PMC article.
-
p53 status in multiple human urothelial cancers: assessment for clonality by the yeast p53 functional assay in combination with p53 immunohistochemistry.Jpn J Cancer Res. 2000 Feb;91(2):181-9. doi: 10.1111/j.1349-7006.2000.tb00930.x. Jpn J Cancer Res. 2000. PMID: 10761705 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous